Skip to main content

Delirium in the Intensive Care Unit

0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ceribell
CeribellCA - Sunnyvale
2 programs
Ceribell Delirium Monitoring SystemN/A1 trial
Ceribell EEG SystemN/A1 trial
Active Trials
NCT07449416Not Yet Recruiting100Est. Dec 2026
NCT07485244Recruiting100Est. Sep 2027

Trial Timeline

Clinical trial activity over time

2026
2027
CeribellCeribell EEG System
CeribellCeribell Delirium Monitoring System

Clinical Trials (2)

Total enrollment: 200 patients across 2 trials

NCT07485244CeribellCeribell EEG System

EEG Abnormalities in Adult ICU Patients With High Risk of Delirium

Start: Apr 2026Est. completion: Sep 2027100 patients
N/ARecruiting
NCT07449416CeribellCeribell Delirium Monitoring System

Ceribell Delirium Monitor Outcomes Pilot Study

Start: Mar 2026Est. completion: Dec 2026100 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 200 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.